| scholarly article | Q13442814 |
| P2093 | author name string | Ghulam Mohammad | |
| Ahmed M Abu El-Asrar | |||
| Mohammad Mairaj Siddiquei | |||
| Mohammad Imtiaz Nawaz | |||
| P2860 | cites work | Nuclear localization and regulation of erk- and rsk-encoded protein kinases | Q24606980 |
| Matrix metalloproteinases | Q28140451 | ||
| Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression | Q28192264 | ||
| Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats | Q28213026 | ||
| Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy | Q28218437 | ||
| Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier | Q28235057 | ||
| Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition | Q28343572 | ||
| Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts | Q28609143 | ||
| Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway. | Q30490801 | ||
| Matrix metalloproteinases in human diabetic and nondiabetic vitreous | Q32058683 | ||
| Signal transduction and transcription factors in rheumatic disease | Q33598827 | ||
| Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis | Q33686973 | ||
| Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras | Q34022639 | ||
| Diabetic retinopathy: targeting vasoregression | Q34448837 | ||
| Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage. | Q35404674 | ||
| Effect of cyclosporin-A on the blood--retinal barrier permeability in streptozotocin-induced diabetes. | Q35609698 | ||
| Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo | Q35747338 | ||
| Matrix metalloproteinases and diabetic vascular complications. | Q36081593 | ||
| Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis | Q36299880 | ||
| Retinal angiogenesis in development and disease | Q36342347 | ||
| Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy | Q36468930 | ||
| Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival | Q37015135 | ||
| Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). | Q37081039 | ||
| Cellular signaling and potential new treatment targets in diabetic retinopathy | Q37089750 | ||
| Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9 | Q37241389 | ||
| Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials | Q37464743 | ||
| miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells | Q39427500 | ||
| Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway | Q39594247 | ||
| Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro | Q40712405 | ||
| Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. | Q40857787 | ||
| Diabetic retinopathy and inflammation: novel therapeutic targets. | Q41012046 | ||
| Role of inflammation in the pathogenesis of diabetic retinopathy | Q41012127 | ||
| Investigation of ocular neovascularization-related genes and oxidative stress in diabetic rat eye tissues after resveratrol treatment | Q42722726 | ||
| The proinflammatory cytokines IL-1beta and TNF-alpha induce the expression of Synoviolin, an E3 ubiquitin ligase, in mouse synovial fibroblasts via the Erk1/2-ETS1 pathway | Q42962015 | ||
| ERK1/2 signaling pathways involved in VEGF release in diabetic rat retina | Q43072986 | ||
| Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress | Q43649151 | ||
| VEGF-initiated blood-retinal barrier breakdown in early diabetes. | Q43723423 | ||
| Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus | Q43758841 | ||
| Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. | Q43992605 | ||
| High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. | Q44492248 | ||
| Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes | Q44536960 | ||
| A central role for inflammation in the pathogenesis of diabetic retinopathy | Q44961996 | ||
| Expression of apoptosis markers in the retinas of human subjects with diabetes | Q44995675 | ||
| Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. | Q45124417 | ||
| Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia | Q46639180 | ||
| Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte | Q46904500 | ||
| Gelatinase B in proliferative vitreoretinal disorders | Q47914078 | ||
| Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. | Q48515308 | ||
| Increased IL-6 levels are not related to NF-κB or HIF-1α transcription factors activity in the vitreous of proliferative diabetic retinopathy. | Q51542620 | ||
| The role of Raf-1 kinase in diabetic retinopathy. | Q54618543 | ||
| The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage | Q57584366 | ||
| Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy | Q62019449 | ||
| MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis | Q62843657 | ||
| Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells | Q73295316 | ||
| Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes | Q73640405 | ||
| Diabetic retinopathy | Q75217418 | ||
| Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy | Q81473347 | ||
| The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis | Q81493593 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 658548 | |
| P577 | publication date | 2013-04-10 | |
| P1433 | published in | Journal of Diabetes Research | Q26841822 |
| P1476 | title | The ERK1/2 Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina | |
| P478 | volume | 2013 |
| Q38365800 | Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option? |
| Q33990723 | ERK1/2/COX-2/PGE2 signaling pathway mediates GPR91-dependent VEGF release in streptozotocin-induced diabetes. |
| Q53665301 | High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina. |
| Q64957438 | Intravitreal AAV2.COMP-Ang1 Attenuates Deep Capillary Plexus Expansion in the Aged Diabetic Mouse Retina. |
| Q37145629 | Modulation of angiogenesis by genetic manipulation of ATF4 in mouse model of oxygen-induced retinopathy [corrected]. |
| Q37379837 | Poly (ADP-ribose) polymerase mediates diabetes-induced retinal neuropathy. |
| Q90728471 | Role of oxidative stress, inflammation, hypoxia and angiogenesis in the development of diabetic retinopathy |
| Q35737656 | Serum Levels of IL-1 β , IL-6, TGF- β , and MMP-9 in Patients Undergoing Carotid Artery Stenting and Regulation of MMP-9 in a New In Vitro Model of THP-1 Cells Activated by Stenting |
| Q37292151 | TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy |
Search more.